Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak

Journal of the National Cancer Institute

Volumn 98, Issue 20, 2006, Pages 1462-1473

  Tomiyama, Arata ^a   Serizawa, Shinobu ^b   Tachibana, Ken ^c   Sakurada, Kaori ^c   Samejima, Hirotsugu ^a   Kuchino, Yoshiyuki ^d   Kitanaka, Chifumi ^c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ANTIMYCIN A1; ARSENOSOBENZENE; AUROVERTIN; AUROVERTIN B; BREFELDIN A; DEOXYGLUCOSE; DNA; ETOPOSIDE; GLUCOSE; INDOMETACIN; NEOPTERIN; OLIGOMYCIN; PROTEIN BAK; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; ROTENONE; TROLOX C; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL TRANSFORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CULTURE MEDIUM; DIMERIZATION; DNA DAMAGE; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME SYNTHESIS; FIBROBLAST; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OLIGOMERIZATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REGULATORY MECHANISM; RESPIRATORY CHAIN; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL FRACTIONATION; CELL SURVIVAL; CONFIDENCE INTERVALS; CROSS-LINKING REAGENTS; DIMERIZATION; DNA DAMAGE; ENDOPLASMIC RETICULUM; FIBROBLASTS; GLYCOLYSIS; HUMANS; IMMUNOPRECIPITATION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE PHOSPHORYLATION; PROTEIN CONFORMATION; RATS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; TUNICAMYCIN; ULTRAVIOLET THERAPY;

EID: 33750220063     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj395     Document Type: Article

References (49)

1. Borner C. The Bcl-2 protein family: Sensors and checkpoints for life-or-death decisions. Mol Immunol 2003;3:615-47.
2. Cory S, Huang DC, Adams JM. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003;22:8590-607.
3. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-30.
4. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001;15:1481-6.
5. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A 2000;97:17872-7.
6. Degenhardt K, Chen G, Lindsten T, White E. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2002;2:193-203.
7. Kirkin V, Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004;1644:229-49.
8. Lee ST, Hoeflich KP, Wasfy GW, Woodgett JR, Leber B, Andrews DW, et al. Bcl-2 targeted to endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts. Oncogene 1999;18:3520-8.
9. Sundararajan R, Cuconati A, Nelson D, White E. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J Biol Chem 2001;276:45120-7.
10. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-41.
11. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000;20:929-35.
12. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-95.
13. Sanchez-Alcazar JA, Ruiz-Cabello J, Hernandez-Munoz I, Pobre PS, de la Torre P, Siles-Rivas E, et al. Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death. J Biol Chem 1997;272:30167-77.
14. Priault M, Camougrand N, Chaudhuri B, Schaeffer J, Manon S. Comparison of the effects of bax-expression in yeast under fermentative and respiratory conditions: Investigation of the role of adenine nucleotides carrier and cytochrome c. FEBS Lett 1999;456:232-8.
15. Harris MH, Vander Heiden MG, Kron SJ, Thompson CB. Role of oxidative phosphorylation in Bax toxicity. Mol Cell Biol 2000;20:3590-6.
16. Chandra D, Liu JW, Tang DG. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 2004;277: 50842-54.
17. Lee MS, Kim JY, Park SY. Resistance of rho(0) cells against apoptosis. Ann N Y Acad Sci 2004;1011:146-53.
18. 1-ATPaseproton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1998;1:327-36.
19. Ikemoto H, Tani E, Ozaki I, Kitagawa H, Arita N. Calphostin C-mediated translocation and integration of Bax into mitochondria induces cytochrome c release before mitochondrial dysfunction. Cell Death Differ 2000; 7:511-20.
20. Tzung SP, Kim KM, Basanez G, Giedt CD, Simon J, Zimmerberg J, et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 2001;3:183-91.
21. Schwarz CS, Evert BO, Seyfried J, Schaupp M, Kunz WS, Vielhaber S, et al. Overexpression of bcl-2 results in reduction of cytochrome c content and inhibition of complex I activity. Biochem Biophys Res Commun 2001;280:1021-7.
22. Vrbacky M, Krijt J, Drahota Z, Melkova Z. Inhibitory effects of Bcl-2 on mitochondrial respiration. Physiol Res 2003;52:545-54.
23. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995;374:811-3.
24. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 1995;374:814-6.
25. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 2004;117:5479-87.
26. Capano M, Crompton M. Bax translocates to mitochondria of heart cells during simulated ischaemia: Involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 2006;395:57-64.
27. Novgorodov SA, Gudz TI, Brierley GP, Pfeiffer DR. Magnesium ion modulates the sensitivity of the mitochondrial permeability transition pore to cyclosporin A and ADP. Arch Biochem Biophys 1994;311:219-28.
28. Sakurai K, Katoh M, Fujimoto Y. Alloxan-induced mitochondrial permeability transition triggered by calcium, thiol oxidation, and matrix ATP. J Biol Chem 2001;276:26942-6.
29. Belaud-Rotureau MA, Leducq N, Macouillard Poulletier de Gannes F, Diolez P, Lacoste L, Lacombe F, et al. Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis 2000;5:551-60.
30. De Giorgi F, Lartigue L, Bauer MK, Schubert A, Grimm S, Hanson GT, et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 2002;16:607-9.
31. Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 2000;7:1174-81.
32. Zamzami N, Kroemer G. The mitochondrion in apoptosis: How Pandora's box opens. Nat Rev Mol Cell Biol 2001;2:67-71.
33. Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: Insights through mathematical models. Cancer Res 2003;63:3847-54.
34. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
35. Hockel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
36. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
37. Wouters BG, Koritzinsky M, Chiu RK, Theys J, Buijsen J, Lambin P. Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol 2003;13:31-41.
38. Warburg O. The metabolism of tumors. London (U.K.): Constable Press; 1930.
39. Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P. Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 2001;11:137-42.
40. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998;94: 715-25.
41. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003;23: 315-28.
42. Weinmann M, Belka C, Plasswilm L. Tumour hypoxia: Impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004;27: 83-90.
43. Schmaltz C, Hardenbergh PH, Wells A, Fisher DE. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 1998;18:2845-54.
44. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 2002;973:443-7.
45. Dong Z, Wang JZ, Yu F, Venkatachalam MA. Apoptosis-resistance of hypoxic cells: Multiple factors involved and a role for IAP-2. Am J Pathol 2003;163:663-71.
46. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000;6:15-9.
47. 2+ stimulate mitochondrial oxidative phosphorylation in saponin-skinned human skeletal muscle fibers due to activation of actomyosin ATPase. Biochim Biophys Acta 1994;1188:373-9.
48. Dubrez L, Coll JL, Hurbin A, Solary E, Favrot MC. Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of BAX protein. J Biol Chem 2001;276:38980-7.
49. Gunter TE, Yule DI, Gunter KK, Eliseev RA, Salter JD. Calcium and mitochondria. FEBS Lett 2004;567:96-102.